Single Column Posts

3 min read

Jeff Horn and Tim Tszyu will be aired live in the United States, as ESPN+ have picked up the fight, which will stream at 5...

5 min read

Indy 500 live: In a normal season is that the finale of what is commonly known as the Month of May in IndyCar racing. The...

4 min read

PSG vs RB Leipzig Live :Are two clubs which have made many enemies among football fans, but maybe not to the way they playwith. On...

4 min read

RB Leipzig v Paris Saint-Germain live stream: How to watch Champions League clash for free – kick-off time, TV Channel and radio coverage.Semifinals start Tuesday...

4 min read

Nets vs Raptors live :After two weeks of seeding games, the action inside the bubble at Disney World will continue with the 2020 NBA Playoffs....

3 min read

Raptors vs Nets Live : After Fourteen Days of seeding Matches, the action in the bubble at Disney World will last using the 2020 NBA...

4 min read

The Utah Jazz do Not have a Solid track record Contrary to the Denver Nuggets this season. Denver won all three matchups this season, all...

5 min read

Barcelona player talks about tonight's Champions League quarter-final against his former club Bayern Munich. The midfielder is well-known for his self-sacrificing style of drama and...

5 min read

Present Barcelona player talks about tonight's Champions League quarter-final against his former team -- Bayern Munich. The midfielder is well-known for his self-sacrificing style of...

6 min read

Current Barcelona player talks about tonight's Champions League quarter-final against his former team -- Bayern Munich. The midfielder is well known for his self-sacrificing manner...

October 24, 2020

The Post Wired

News On Trending

Sizzling Stock: REGENXBIO Inc. (NASDAQ:RGNX)

Spread the love

REGENXBIO Inc. (NASDAQ:RGNX) changed -0.68% to recent value of $ 65.7. The stock transacted shares during most recent the day were 751949 shares however it has an average volume of 706.70K shares. It spotted trading -22.80% off of the 52-week high price. On the other end, the stock has been noted 237.79% away from the low price over the last 52-weeks.

RGNX has a gross margin of 97.20% as compared to operating margin of -53.30% and its profit margin remained -51.40% for the last 12 months. The company has earnings of $ 53.10M and made $142.30M revenue for the last 12 month. Its earnings per share (EPS) expected to touch remained -2.70% for this year while earning per share for the next 5-years is expected to reach at 4.00%.

REGENXBIO Inc. (NASDAQ:RGNX), a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy based on its proprietary NAV® Technology Platform, today declared the closing of its previously announced underwritten public offering of 2,700,000 shares of its common stock at a price to the public of $65.00 per share, as well as the exercise in full of the underwriters’ option to purchase 405,000 additional shares at the public offering price. Including the option exercise, the total gross proceeds to REGENXBIO are expected to be approximately $201.8 million, before deducting the underwriting discounts and commissions and estimated offering expenses.

Morgan Stanley, BofA Merrill Lynch and Barclays acted as joint book-running managers. Raymond James acted as co-manager of the offering.

The company has 33.43M of outstanding shares and 26.16M shares were floated in the market. According to the most recent quarter its current ratio was 17.7 that represents company’s ability to meet its current financial obligations. The price moved ahead of -7.63% from the mean of 20 days, -4.77% from 50 and performed 57.44% from 200 days average price. Company’s performance for the week was -7.20%, -12.52% for month and yearly performance remained 215.11%.